Sugi Predict

Sugi Predict / Compounds / SCHEMBL3765607

SCHEMBL3765607

SCHEMBL3765607

CC(C)(C)OC(=O)c1ccn[c]c1-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGDS O60760 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ GRM6 O15303 1/20 0.39
▸ ABCG2 Q9UNQ0 2/20 0.38
▸ GABRA1 P14867 2/20 0.37
▸ GABRG2 P18507 2/20 0.37
▸ GABRB3 P28472 2/20 0.37
▸ GABRA5 P31644 2/20 0.37
▸ GABRA3 P34903 2/20 0.37
▸ GABRA2 P47869 2/20 0.37
▸ GABRA6 Q16445 2/20 0.37
▸ ADRA1A P35348 1/20 0.37
▸ ADRA1B P35368 1/20 0.37
▸ CKS1B P61024 3/20 0.34
▸ SKP1 P63208 3/20 0.34
▸ SKP2 Q13309 3/20 0.34
▸ TSHR P16473 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3761439 0.80 TSHR (0.51) ALDH1A1LMNATSHRHSD17B10TDP1
SCHEMBL3761229 0.79 SMN1; SMN2 (0.40) ALDH1A1TSHRHSD17B10NPC1RAB9A
SCHEMBL3759347 0.78 ALDH1A1 (0.41) ALDH1A1LMNATSHRTDP1NPC1
SCHEMBL3766118 0.77 GPR119 (0.35) CKS1BSKP1SKP2GBA1POLB
SCHEMBL3755022 0.77 CKS1B (0.37) CKS1BSKP1SKP2GBA1POLB
SCHEMBL3761415 0.75 BCAT2 (0.46) ALDH1A1TSHRHSD17B10MEN1NPC1
SCHEMBL3758759 0.75 KMT2A (0.50) ALDH1A1ADRA1AADRA1BTDP1ATR
SCHEMBL3769036 0.75 GAA (0.41) ALDH1A1HSD17B10NPC1GAARAB9A
SCHEMBL3764949 0.74 DHODH (0.38) ALDH1A1HSD17B10MEN1NPC1GAA
SCHEMBL11452528 0.74 ALDH1A1 (0.44) ALDH1A1LMNATDP1MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 — — EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 — — US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 — — US disclosed
WO-2009122148-A1 FUSED THIOPHENE AND THIAZOLE DERIVATIVES AS PI3K KINASE INHIBITORS UCB PHARMA S.A. (BE) 2009-10-08 — — WO disclosed
WO-2009071890-A1 TRICYCLIC KINASE INHIBITORS UCB PHARMA S.A. (BE) 2009-06-11 — — WO disclosed
WO-2009071895-A1 FUSED THIAZOLE AND THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA S.A. (BE) 2009-06-11 — — WO disclosed
EP-2029570-A1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB Pharma S.A. (BE) 2009-03-04 — — EP disclosed
WO-2007141504-A1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA S.A. (BE) 2007-12-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA HPGDS 1743/4885ALDH1A1 3061/4885LMNA 4870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.